Compounds > prostratin
Page last updated: 2024-08-24

prostratin and triazoles

prostratin has been researched along with triazoles in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Brass, AL; Chin, CR; Elledge, SJ; Gaiha, GD; Gao, G; John, SP; Pertel, T; Qu, H; Walker, BD; Zhu, J1
Guo, J; Li, Z; Wu, Y; Zhou, Q1
Bullen, CK; Durand, CM; Hill, AL; Laird, GM; Martin, AR; Rosenbloom, DI; Siliciano, JD; Siliciano, RF1
Chen, H; Gao, X; Lin, T; Lu, H; Ni, M; Shan, W; Wang, C; Xue, Y; Yang, S; You, H; Zhou, Q1
Akari, H; Irie, K; Kikumori, M; Murata, M; Seki, Y; Tan, W; Tang, Y; Wardani, NP; Washizaki, A1

Other Studies

5 other study(ies) available for prostratin and triazoles

ArticleYear
Reactivation of latent HIV-1 by inhibition of BRD4.
    Cell reports, 2012, Oct-25, Volume: 2, Issue:4

    Topics: Azepines; CD4-Positive T-Lymphocytes; Cell Cycle Proteins; Cells, Cultured; Gene Expression; HEK293 Cells; HeLa Cells; HIV-1; Humans; Jurkat Cells; Nuclear Proteins; Phorbol Esters; RNA Interference; RNA, Small Interfering; tat Gene Products, Human Immunodeficiency Virus; Transcription Factors; Triazoles; Virus Activation; Virus Latency

2012
The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
    Nucleic acids research, 2013, Jan-07, Volume: 41, Issue:1

    Topics: Anti-HIV Agents; Azepines; Cell Cycle Proteins; Cyclin-Dependent Kinase 9; HeLa Cells; HIV; Humans; Jurkat Cells; Nuclear Proteins; Phorbol Esters; Phosphorylation; Positive Transcriptional Elongation Factor B; Promoter Regions, Genetic; Ribonucleoproteins, Small Nuclear; RNA Polymerase II; tat Gene Products, Human Immunodeficiency Virus; Transcription Factors; Transcriptional Activation; Transcriptional Elongation Factors; Triazoles; Virus Latency

2013
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.
    The Journal of clinical investigation, 2015, Volume: 125, Issue:5

    Topics: Adult; Anti-HIV Agents; Azepines; Bryostatins; CD4-Positive T-Lymphocytes; Cells, Cultured; Disulfiram; Drug Evaluation, Preclinical; Drug Synergism; Female; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Lymphokines; Male; Middle Aged; Phorbol Esters; Protein Kinase C; RNA, Messenger; RNA, Viral; Transcription, Genetic; Triazoles; Virion; Virus Latency

2015
A Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNP.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Azepines; Biological Products; Cell Survival; Drug Synergism; Fallopia japonica; Green Fluorescent Proteins; HIV-1; Humans; Jurkat Cells; Phorbol Esters; Positive Transcriptional Elongation Factor B; Proanthocyanidins; Ribonucleoproteins, Small Nuclear; tat Gene Products, Human Immunodeficiency Virus; Terminal Repeat Sequences; Time Factors; Transcription, Genetic; Triazoles; Virus Latency

2015
The Novel PKC Activator 10-Methyl-Aplog-1 Combined with JQ1 Induced Strong and Synergistic HIV Reactivation with Tolerable Global T Cell Activation.
    Viruses, 2021, 10-09, Volume: 13, Issue:10

    Topics: Anti-HIV Agents; Azepines; Bryostatins; CD4-Positive T-Lymphocytes; Cell Line; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Phorbol Esters; Signal Transduction; Triazoles; Virus Latency

2021